May 8, 2026
avatar-torie-bosch
First Opinion editor

On the “First Opinion Podcast” this week, Will Flanary — the ophthalmologist better known on social media as Dr. Glaucomflecken — returns for his second appearance. We talked about cosmetic eye color-changing surgery (“I hate it so much,” he told me), the return of “Scrubs,” the imperative for ethical doctors to be on social media — and, most of all, about his advocacy around a situation in Oregon. A hospital system in Eugene, Oregon, planned replace its community-based emergency department physician group with staffing provided by a national company. In response, Dr. Glaucomflecken and others began organizing. It’s just the most recent example of his advocacy, which uses humor to introduce his audience to stories that might not otherwise cross his radar.

“There’s a lot people in hospital administration, in health insurance, in private equity, doing bad things for patients and for doctors. And one unifying characteristic of every story … is that they don’t want people to know what’s happening. They want to keep it out of the news,” he told me. “They don’t want this kind of scrutiny because they know this is really unpopular and that maybe this isn’t the best for patient care, but it’s maybe good for pocketbooks, maybe good for other reasons that are not as altruistic.”

Listen (or watch — we now have a video podcast! Don’t judge my hair!) here.

Also: Do not miss Saturday’s First Opinion on RFK Jr. and bioethical considerations about collecting animal parts, written by someone with actual firsthand experience collecting raccoon genitals.

Recommendation of the week: The New York Times’ feature on a young woman who used an experimental synthetic drug to try to wean herself off kratom illustrates how important Reddit has become to a DIY knowledge ecosystem about gray-market drugs — for better or worse. (See also: this First Opinion from March on how people turn to Reddit for help with telehealth-prescribed ketamine.)



CDC/SCIENCE PHOTO LIBRARY

I’m fighting misinformation online. False hantavirus claims follow a now-familiar playbook

Hantavirus outbreak is serious but limited. Online, it's another story. Katrine Wallace, a medical misinformation expert, explains why ivermectin is back.

By Katrine Wallace


Are blue zones real? Answering that question is harder than ever

Examining the science and growing commercialization of 'blue zones,' famed longevity hot spots that seem to be fading – if they ever existed at all.

By Shelley Wood and Eric J. Topol


We need more men in nursing

Nursing offers great career opportunities — and gender diversity among health care workers helps patients.

By Nicholas A. Giordano


Adobe

STAT+ | Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting

Medicare's new RAPID pathway is a breakthrough for adults. Children are still waiting.

By Kolaleh Eskandanian


Eugene Braunwald, ‘father of modern cardiology,’ told me he had two dreams. One came true

Eugene Braunwald, who was widely recognized as 'the father of modern cardiology,' died on April 22 at the age of 96.

By Lawrence K. Altman


STAT+ | Ambiguous loss: a peculiar kind of grief in dementia care

Dementia leads to a grief known as ambiguous loss. American medicine and culture need to talk about it.

By Jason Karlawish


Dr. Glaucomflecken wants to make a stink

Will Flanary, aka Dr. Glaucomflecken, talks advocacy, cosmetic eye surgery, and ‘Scrubs’ on the “First Opinion Podcast.”

By Torie Bosch


Trump’s executive order on psychedelics is the right move. But is my field ready for it?

Trump’s executive order on psychedelics is the right move, a researcher writes. But he’s not sure his field is ready.

By Peter S. Hendricks


The ‘brain drain’ narrative about health professionals misses half of the story

Ministries of health and international funders need to shift attention from managing health care workers' exits to enabling consequential return.

By Maia Chankseliani


Three passengers are dead and seven people are ill from a hantavirus outbreak aboard the MV Hondius cruise ship.
AFP via Getty Images

The cruise ship hantavirus outbreak is a warning sign to the U.S.

A suspected hantavirus outbreak at sea, the World Cup, and a U.S. that cut itself off from the World Health Organization.

By Krutika Kuppalli


Mifepristone court ruling makes drug development riskier for everyone

Recent ruling on mifepristone abortion drug could unwind decades of scientific review and undermine the FDA.

By Grace Colón


STAT+ | China’s strict new supply chain regulations could create massive problems for Western biopharma companies

New regulations exploit the commercial indispensability that China’s pharmaceutical ecosystem has built over the past decade.

By Dennis Kwok


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.